BioSpace News Archive

Neurona Therapeutics Inc. today announced the successful completion of a $41.5 million financing.

IMMUNOPRECISE ANTIBODIES LTD and Eurofins Discovery announced a commercial collaboration.

Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical study of ATRS-1902 for adrenal crisis rescue.

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, announced that the Company will be included in the Russell Microcap® Index effective after the U.S. market opens on Monday, June 28, 2021, as based on the preliminary list of additions.

Aidoc, leading provider of AI solutions for medical imaging and icometrix, world leader in imaging AI solutions for patients with neurological conditions, announced a partnership that will provide an AI-based Stroke suite for rapid triage of patients with suspected stroke.

BELKIN Laser, the Israel-based medical device company committed to bringing an accessible, automated, fast, and non-invasive glaucoma laser treatment to market is pleased to announce the appointment of Andrew Webb as Chief Commercial Officer.

Global Contract Research Organization (CRO) Avania to Manage All Regulatory Affairs in Connection with JanOne’s Phase 2b Trial Preparedness and Execution

Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, announced the company received a National Sponsor award from the TSC Alliance recognizing the company’s support for the Step Forward to Cure TSC® event.

New research published in the Journal of Medicinal Food suggests eating prunes each day can improve risk factors for cardiovascular disease (CVD) including raising antioxidant capacity and reducing inflammation among healthy, postmenopausal women.

Infinity BiologiX, LLC (IBX), a leading next-generation central laboratory providing sample collection and processing, storage, analytical services, and scientific and technical support, has named Robin Grimwood as Chief Executive Officer.